Lori M. Henderson - May 27, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: General Counsel and Secretary
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: May 27, 2021
Transactions value $: -$1,051,710
Form type: 4
Date filed: 5/28/2021, 08:45 AM
Previous filing: May 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$98K	+6.6K	+732.52%	$14.85^*	7.5K	May 27, 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	-$1.15M	-6.6K	-87.99%	$174.20	901	May 27, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-6.6K	-1.97%	$0.00	328K	May 27, 2021	Common Stock	6.6K	$14.85	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
F2	25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.